180 related articles for article (PubMed ID: 22797854)
1. Tumor regression with a combination of drugs interfering with the tumor metabolism: efficacy of hydroxycitrate, lipoic acid and capsaicin.
Schwartz L; Guais A; Israël M; Junod B; Steyaert JM; Crespi E; Baronzio G; Abolhassani M
Invest New Drugs; 2013 Apr; 31(2):256-64. PubMed ID: 22797854
[TBL] [Abstract][Full Text] [Related]
2. A combination of alpha lipoic acid and calcium hydroxycitrate is efficient against mouse cancer models: preliminary results.
Schwartz L; Abolhassani M; Guais A; Sanders E; Steyaert JM; Campion F; Israël M
Oncol Rep; 2010 May; 23(5):1407-16. PubMed ID: 20372858
[TBL] [Abstract][Full Text] [Related]
3. Adding a combination of hydroxycitrate and lipoic acid (METABLOC™) to chemotherapy improves effectiveness against tumor development: experimental results and case report.
Guais A; Baronzio G; Sanders E; Campion F; Mainini C; Fiorentini G; Montagnani F; Behzadi M; Schwartz L; Abolhassani M
Invest New Drugs; 2012 Feb; 30(1):200-11. PubMed ID: 20931262
[TBL] [Abstract][Full Text] [Related]
4. Screening of well-established drugs targeting cancer metabolism: reproducibility of the efficacy of a highly effective drug combination in mice.
Abolhassani M; Guais A; Sanders E; Campion F; Fichtner I; Bonte J; Baronzio G; Fiorentini G; Israël M; Schwartz L
Invest New Drugs; 2012 Aug; 30(4):1331-42. PubMed ID: 21655919
[TBL] [Abstract][Full Text] [Related]
5. Metabolic therapies inhibit tumor growth in vivo and in silico.
da Veiga Moreira J; Hamraz M; Abolhassani M; Schwartz L; Jolicœur M; Peres S
Sci Rep; 2019 Feb; 9(1):3153. PubMed ID: 30816152
[TBL] [Abstract][Full Text] [Related]
6. Local Administration of Caloric Restriction Mimetics to Promote the Immune Control of Lung Metastases.
Le Noci V; Sommariva M; Bianchi F; Triulzi T; Tagliabue E; Balsari A; Sfondrini L
J Immunol Res; 2019; 2019():2015892. PubMed ID: 31321243
[TBL] [Abstract][Full Text] [Related]
7. Metabolic treatment of cancer: intermediate results of a prospective case series.
Schwartz L; Buhler L; Icard P; Lincet H; Steyaert JM
Anticancer Res; 2014 Feb; 34(2):973-80. PubMed ID: 24511042
[TBL] [Abstract][Full Text] [Related]
8. Assessing the therapeutic efficacy of VEGFR-1-targeted polymer drug conjugates in mouse tumor models.
Shamay Y; Golan M; Tyomkin D; David A
J Control Release; 2016 May; 229():192-199. PubMed ID: 27001892
[TBL] [Abstract][Full Text] [Related]
9. CENU treatment induced bystander effects which are effective on parental and non-parental tumors and have a phospholipid metabolism proton NMR spectroscopy signature.
Merle P; Morvan D; Madelmont JC; Caillaud D; Demidem A
Int J Oncol; 2006 Sep; 29(3):637-42. PubMed ID: 16865279
[TBL] [Abstract][Full Text] [Related]
10. Tyroservatide therapy for tumor growth, invasion and metastasis of Lewis lung carcinoma and human lung carcinoma A549.
Zheng M; Lu R; Che X; Li J; Zhou C; Wang L; Xu Q; Cao H; Li Q; Yao Z
Oncology; 2006; 70(6):418-26. PubMed ID: 17245103
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways.
Morvan D; Demidem A
Cancer Res; 2007 Mar; 67(5):2150-9. PubMed ID: 17332345
[TBL] [Abstract][Full Text] [Related]
12. SK-216, an inhibitor of plasminogen activator inhibitor-1, limits tumor progression and angiogenesis.
Masuda T; Hattori N; Senoo T; Akita S; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Kohno N
Mol Cancer Ther; 2013 Nov; 12(11):2378-88. PubMed ID: 23990114
[TBL] [Abstract][Full Text] [Related]
13. Breaking the 'harmony' of TNF-α signaling for cancer treatment.
Sasi SP; Yan X; Enderling H; Park D; Gilbert HY; Curry C; Coleman C; Hlatky L; Qin G; Kishore R; Goukassian DA
Oncogene; 2012 Sep; 31(37):4117-27. PubMed ID: 22158049
[TBL] [Abstract][Full Text] [Related]
14. Contribution of host-derived tissue factor to tumor neovascularization.
Yu J; May L; Milsom C; Anderson GM; Weitz JI; Luyendyk JP; Broze G; Mackman N; Rak J
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1975-81. PubMed ID: 18772494
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine.
Albini A; D'Agostini F; Giunciuglio D; Paglieri I; Balansky R; De Flora S
Int J Cancer; 1995 Mar; 61(1):121-9. PubMed ID: 7705924
[TBL] [Abstract][Full Text] [Related]
16. Ticagrelor prevents tumor metastasis via inhibiting cell proliferation and promoting platelet apoptosis.
Meng X; Liu W; Yang H; Cao Z; He H; Zheng K; Chen Y; Su J; Lv J; Sun J; Li P; Ding S; Ahmad N; Qian J; Zhou Y
Anticancer Drugs; 2020 Nov; 31(10):1012-1017. PubMed ID: 33009034
[TBL] [Abstract][Full Text] [Related]
17. Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature.
Rybinski K; Imtiyaz HZ; Mittica B; Drozdowski B; Fulmer J; Furuuchi K; Fernando S; Henry M; Chao Q; Kline B; Albone E; Wustner J; Lin J; Nicolaides NC; Grasso L; Zhou Y
Oncotarget; 2015 Sep; 6(28):25429-40. PubMed ID: 26327620
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of neuropathies].
Kempler P
Orv Hetil; 2010 Jan; 151(2):62-5. PubMed ID: 20061234
[No Abstract] [Full Text] [Related]
19. Ginkgo biloba exocarp extracts induces apoptosis in Lewis lung cancer cells involving MAPK signaling pathways.
Cao C; Su Y; Han D; Gao Y; Zhang M; Chen H; Xu A
J Ethnopharmacol; 2017 Feb; 198():379-388. PubMed ID: 28115284
[TBL] [Abstract][Full Text] [Related]
20. Effects of FK317, a novel anti-cancer agent, on survival of mice bearing B16BL6 melanoma and Lewis lung carcinoma.
Inami M; Kawamura I; Tsujimoto S; Nishigaki F; Matsumoto S; Naoe Y; Sasakawa Y; Matsuo M; Manda T; Goto T
Cancer Lett; 2002 Jul; 181(1):39-45. PubMed ID: 12430177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
